NeoGenomics provides one of the most comprehensive vaccines and immunotherapies laboratory services available for Oncology, Immuno-Oncology and Infectious diseases. Our global cross-functional teams include recognized leaders in the vaccine industry and are based across a CAP/CLIA global laboratory network in US (California and Houston), Switzerland and Singapore. Our scientific teams have decades of executive experience in vaccine testing using cutting edge technology to support the development of vaccine programs in oncology and infectious diseases from early stage to post-approval.
Documents & Links
Testing Capabilities for Vaccines and Infectious DiseasesNeoGenomics has the ability to develop, transfer, qualify, and fully validate custom assays aligned with each study requirement.